Search Results
DDx Strength: Weak
mogamulizumab-kpkc, Rash or multiple lesions

Edit Findings
Mogamulizumab-associated rash
Exanthematous drug eruptionExanthematous drug eruption
FolliculitisFolliculitis
Herpes zosterHerpes zoster
Drug-induced photosensitive reactionDrug-induced photosensitive reaction
Bacterial sepsisBacterial sepsis
Drug-induced hepatotoxicity
Cytomegalovirus infectionCytomegalovirus infection
Radiation dermatitisRadiation dermatitis
PsoriasisPsoriasis
Alopecia areataAlopecia areata
Lichenoid drug eruptionLichenoid drug eruption
Interstitial granulomatous drug reactionInterstitial granulomatous drug reaction
Stevens-Johnson syndromeStevens-Johnson syndrome
Toxic epidermal necrolysisToxic epidermal necrolysis
VitiligoVitiligo
Acute coronary syndrome
Drug-induced abdominal pain
Drug-induced cough
Drug-induced diarrhea
Drug-induced nausea or vomiting
Drug-induced weight gain
Drug-induced alopeciaDrug-induced alopecia
Drug-induced anorexia
Drug-induced constipation
Drug-induced depressive disorder
Drug-induced dizziness
Drug-induced fatigue
Drug-induced headache
Drug-induced hypertension
Drug-induced leukopenia
Drug-induced myopathies
Drug-induced weight loss
Peripheral neuropathy
Prolonged QT interval
Drug-induced diabetes
Drug-induced fever
Drug-induced heart failure
Drug-induced muscle spasm
Hypercalcemia
Myocarditis
Pneumocystis jirovecii pneumoniaPneumocystis jirovecii pneumonia
Polymyositis
Drug-induced anemia
Autoimmune hepatitis
Takotsubo cardiomyopathy